Key references: Diminished mobility due to multiple sclerosis

  • Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, et al. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 2009;373(9665):732–8. https://www.ncbi.nlm.nih.gov/pubmed/19249634
  • Jensen H, Ravnborg M, Mamoei S, Dalgas U, Stenager E. Changes in cognition, arm function and lower body function after slow-release Fampridine treatment. Mult Scler 2014;20(14):1872–80. https://www.ncbi.nlm.nih.gov/pubmed/24852920